Using alpha-defensin and synovial proteins to diagnose pediatric septic arthritis
Official title: Alpha-Defensin and Synovial Proteins to Improve Detection of Pediatric Septic Arthritis
Run by Hospital for Special Surgery, New York · NCT03704766 · Data updated 2026-11-12
This study is testing if certain proteins in joint fluid can help doctors better diagnose septic arthritis in children who might have joint infections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | Any age to 17 Years |
| Sex | All |
| Enrollment | 442 (estimated) |
| Sponsor | Hospital for Special Surgery, New York Academic / other |
| Locations | 3 sites (Atlanta, Georgia and 2 other locations) |
| Status | Recruiting |
| Started | June 28, 2016 |
| Main results expected | November 2026 |
| Study ends | January 2027 |
| Registry record updated | July 29, 2026 |
| Trial ID | NCT03704766 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are pediatric patients under 18 years old who are undergoing joint aspiration due to suspected infection or inflammation.
✕Probably not a fit
Patients with major joint trauma within the past 8 weeks or those with a recent history of infection may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to improve the diagnosis of septic arthritis in children by evaluating the sensitivity and specificity of alpha-defensin and other synovial biomarkers in joint fluid samples. Pediatric patients under 18 years old, suspected of having joint infections, will undergo joint aspiration to collect synovial fluid for analysis. The study will compare samples from patients with suspected infections to those from normative controls undergoing unrelated procedures. Various assays will be performed on the collected fluid to identify potential biomarkers indicative of bacterial joint infections.
Why it matters
Potential benefit: If successful, this study could lead to faster and more accurate diagnoses of septic arthritis in children, potentially reducing the need for unnecessary surgical interventions.
How similar studies have gone: Previous studies have shown that the alpha-defensin assay has high sensitivity and specificity for diagnosing joint infections, indicating potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria- Septic Cases and Inflamed, Non-Septic Comparators: * Synovial fluid is obtained to assess for infection or inflammatory/rheumatologic disease (all medium and large joints will be included: hip, knee, ankle, shoulder, subtalar, elbow, and wrist joints) * Patients with recent antibiotic exposure are eligible to participate but will be analyzed separately Inclusion Criteria- Normative Controls: * Patients undergoing a procedure unrelated to infection (the procedure may be arthroscopy, or an open or percutaneous bony or soft tissue procedure) Exclusion Criteria- All Participants: * Family declines to participate/consent * Patients with a major joint trauma (such as a documented ligament tear or fracture) within the past 8 weeks are not eligible to have that joint aspirated, but could have another joint aspirated Exclusion Criteria- Normative Controls: * A history of recent infection (within the past 3 months) * Received antibiotics in the past 7 days
Where it's running
-
Children's Healthcare of Atlanta
Atlanta, Georgia, United States Recruiting -
Hospital for Special Surgery
New York, New York, United States Recruiting -
Campbell Clinic
Collierville, Tennessee, United States Not yet recruiting
Study contacts
- Principal investigator: Emily R Dodwell, MD, MPH — The Hospital for Special Surgery
- Study coordinator: Grace Wang, BA
- Email: wangg@hss.edu
- Phone: 212-774-2121
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Oral antibiotics for treating bone and joint infections in children
This study is testing if giving oral antibiotics first can effectively and safely treat uncomplicated bone and joint infections in children and teens aged 3 months to 17 years.
-
High-resolution infrared imaging to detect bone, joint and soft-tissue infections in children
We will test whether a 10-second high-resolution infrared thermal video can help detect bone, joint, or soft-tissue infections in children up to 15 years old.
-
Trimethoprim-sulfamethoxazole versus clindamycin for children with invasive MRSA infections
This will see if trimethoprim-sulfamethoxazole works as well as clindamycin to treat invasive MRSA infections in children aged 60 days to 18 years.
-
Comparing two types of spacers for treating knee joint infections
This study is testing which type of spacer works better for treating knee joint infections in patients who have had knee replacement surgery.
-
Comparing infection rates after hip replacement using a special solution versus saline
This study is testing if a special solution can lower the risk of joint infections after hip replacement surgery compared to regular saline.
-
Oral antibiotics for treating bone and joint infections in children
This study tests if giving only oral antibiotics can effectively treat bone and joint infections in children, compared to the usual method that starts with IV antibiotics.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.